Monitoring Hepatocellular Carcinoma Using Tumor Content in Circulating Cell-Free DNA.
Shifeng LianChenyu LuFugui LiXia YuLimei AiBiao-Hua WuXueyi GongWenjing ZhouXuejun LiangJiyun ZhanYong YuanFang FangZhiwei LiuMingfang JiZongli ZhengPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
The tumor content in ccfDNA is correlated with tumor burden and may help in monitoring HCC 1 yearearlier than clinical diagnosis and in predicting patient prognosis.
Keyphrases